{"id":21478,"date":"2014-08-18T18:15:53","date_gmt":"2014-08-18T20:15:53","guid":{"rendered":"http:\/\/eldigitaldeasturias.com\/magazine365\/?p=21478"},"modified":"2014-08-18T18:15:53","modified_gmt":"2014-08-18T20:15:53","slug":"cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales","status":"publish","type":"post","link":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/","title":{"rendered":"Cient\u00edficos Vall d&#8217;Hebron validan uso de un inhibidor en tumores cerebrales"},"content":{"rendered":"<p><img fetchpriority=\"high\" decoding=\"async\" class=\"alignleft size-medium wp-image-21479\" alt=\"6564776w\" src=\"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w-360x220.jpg\" width=\"360\" height=\"220\" srcset=\"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w-360x220.jpg 360w, https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w-650x397.jpg 650w, https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w-768x469.jpg 768w, https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w-150x92.jpg 150w, https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w-450x275.jpg 450w, https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w-696x425.jpg 696w, https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w-687x420.jpg 687w, https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w.jpg 800w\" sizes=\"(max-width: 360px) 100vw, 360px\" \/>Barcelona, 18 ago (EFE).- Un grupo de cient\u00edficos del hospital Vall d&#8217;Hebron de Barcelona ha logrado por primera vez validar el uso de un inhibidor de Myc, una prote\u00edna clave implica en el desarrollo de tumores cerebrales m\u00e1s frecuentes como el glioma.<\/p>\n<p>El trabajo, que hoy se publica en Nature Comunications, est\u00e1 liderado por la doctor Laura Soucek y confirma que la inhibici\u00f3n de Myc impide que las c\u00e9lulas tumorales se dividan y proliferen de una forma eficiente, seg\u00fan ha informado en un comunicado el hospital barcelon\u00e9s.<\/p>\n<p>La investigaci\u00f3n no solo supone uno nuevo enfoque terap\u00e9utico del glioma, el tumor cerebral m\u00e1s frecuente y con \u00abtratamientos en gran medida ineficaces\u00bb, sino que tambi\u00e9n nos aporta novedades sobre la biolog\u00eda de Myc que pueden repercutir en su impacto terap\u00e9utico.<\/p>\n<p>La doctora Soucek ha comentado que despu\u00e9s de \u00ablos primeros y prometedores resultados, la gran preocupaci\u00f3n del equipo era conseguir que estos hallazgos se pudieran aplicar en tumores humanos\u00bb.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Barcelona, 18 ago (EFE).- Un grupo de cient\u00edficos del hospital Vall d&#8217;Hebron de Barcelona ha logrado por primera vez validar el uso de un inhibidor de Myc, una prote\u00edna clave implica en el desarrollo de tumores cerebrales m\u00e1s frecuentes como el glioma. El trabajo, que hoy se publica en Nature Comunications, est\u00e1 liderado por la<\/p>\n","protected":false},"author":1,"featured_media":21479,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[224],"tags":[],"class_list":{"0":"post-21478","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-noticias-actualidad"},"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 4.9.5.2 - aioseo.com -->\n\t<meta name=\"description\" content=\"Barcelona, 18 ago (EFE).- Un grupo de cient\u00edficos del hospital Vall d&#039;Hebron de Barcelona ha logrado por primera vez validar el uso de un inhibidor de Myc, una prote\u00edna clave implica en el desarrollo de tumores cerebrales m\u00e1s frecuentes como el glioma. El trabajo, que hoy se publica en Nature Comunications, est\u00e1 liderado por la\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<meta name=\"google-site-verification\" content=\"UA-38556648-1\" \/>\n\t<meta name=\"keywords\" content=\"noticias y actualidad\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 4.9.5.2\" \/>\n\t\t<meta property=\"og:locale\" content=\"es_ES\" \/>\n\t\t<meta property=\"og:site_name\" content=\"El Digital de Asturias \u2013 Revista de ocio, turismo y estilo de vida\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Cient\u00edficos Vall d\u2019Hebron validan uso de un inhibidor en tumores cerebrales | El Digital de Asturias\" \/>\n\t\t<meta property=\"og:description\" content=\"Barcelona, 18 ago (EFE).- Un grupo de cient\u00edficos del hospital Vall d&#039;Hebron de Barcelona ha logrado por primera vez validar el uso de un inhibidor de Myc, una prote\u00edna clave implica en el desarrollo de tumores cerebrales m\u00e1s frecuentes como el glioma. El trabajo, que hoy se publica en Nature Comunications, est\u00e1 liderado por la\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t\t<meta property=\"og:image:height\" content=\"489\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2014-08-18T20:15:53+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2014-08-18T20:15:53+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Cient\u00edficos Vall d\u2019Hebron validan uso de un inhibidor en tumores cerebrales | El Digital de Asturias\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Barcelona, 18 ago (EFE).- Un grupo de cient\u00edficos del hospital Vall d&#039;Hebron de Barcelona ha logrado por primera vez validar el uso de un inhibidor de Myc, una prote\u00edna clave implica en el desarrollo de tumores cerebrales m\u00e1s frecuentes como el glioma. El trabajo, que hoy se publica en Nature Comunications, est\u00e1 liderado por la\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\\\/#article\",\"name\":\"Cient\\u00edficos Vall d\\u2019Hebron validan uso de un inhibidor en tumores cerebrales | El Digital de Asturias\",\"headline\":\"Cient\\u00edficos Vall d&#8217;Hebron validan uso de un inhibidor en tumores cerebrales\",\"author\":{\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/wp-content\\\/uploads\\\/2014\\\/08\\\/6564776w.jpg\",\"width\":800,\"height\":489},\"datePublished\":\"2014-08-18T18:15:53+02:00\",\"dateModified\":\"2014-08-18T18:15:53+02:00\",\"inLanguage\":\"es-ES\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\\\/#webpage\"},\"articleSection\":\"Noticias y Actualidad\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/category\\\/noticias-actualidad\\\/#listItem\",\"name\":\"Noticias y Actualidad\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/category\\\/noticias-actualidad\\\/#listItem\",\"position\":2,\"name\":\"Noticias y Actualidad\",\"item\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/category\\\/noticias-actualidad\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\\\/#listItem\",\"name\":\"Cient\\u00edficos Vall d&#8217;Hebron validan uso de un inhibidor en tumores cerebrales\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\\\/#listItem\",\"position\":3,\"name\":\"Cient\\u00edficos Vall d&#8217;Hebron validan uso de un inhibidor en tumores cerebrales\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/category\\\/noticias-actualidad\\\/#listItem\",\"name\":\"Noticias y Actualidad\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/#organization\",\"name\":\"El digital de Asturias\",\"description\":\"Revista de ocio, turismo y estilo de vida\",\"url\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.eldigitaldeasturias.com\\\/noticias\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/EDA.jpg\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\\\/#authorImage\",\"url\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/wp-content\\\/litespeed\\\/avatar\\\/e571bcf59a0edd6fa6838245a470f2fe.jpg?ver=1775154774\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\\\/#webpage\",\"url\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\\\/\",\"name\":\"Cient\\u00edficos Vall d\\u2019Hebron validan uso de un inhibidor en tumores cerebrales | El Digital de Asturias\",\"description\":\"Barcelona, 18 ago (EFE).- Un grupo de cient\\u00edficos del hospital Vall d'Hebron de Barcelona ha logrado por primera vez validar el uso de un inhibidor de Myc, una prote\\u00edna clave implica en el desarrollo de tumores cerebrales m\\u00e1s frecuentes como el glioma. El trabajo, que hoy se publica en Nature Comunications, est\\u00e1 liderado por la\",\"inLanguage\":\"es-ES\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/wp-content\\\/uploads\\\/2014\\\/08\\\/6564776w.jpg\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\\\/#mainImage\",\"width\":800,\"height\":489},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\\\/#mainImage\"},\"datePublished\":\"2014-08-18T18:15:53+02:00\",\"dateModified\":\"2014-08-18T18:15:53+02:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/#website\",\"url\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/\",\"name\":\"El Digital de Asturias\",\"description\":\"Revista de ocio, turismo y estilo de vida\",\"inLanguage\":\"es-ES\",\"publisher\":{\"@id\":\"https:\\\/\\\/eldigitaldeasturias.com\\\/magazine365\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>Cient\u00edficos Vall d\u2019Hebron validan uso de un inhibidor en tumores cerebrales | El Digital de Asturias<\/title>\n\n","aioseo_head_json":{"title":"Cient\u00edficos Vall d\u2019Hebron validan uso de un inhibidor en tumores cerebrales | El Digital de Asturias","description":"Barcelona, 18 ago (EFE).- Un grupo de cient\u00edficos del hospital Vall d'Hebron de Barcelona ha logrado por primera vez validar el uso de un inhibidor de Myc, una prote\u00edna clave implica en el desarrollo de tumores cerebrales m\u00e1s frecuentes como el glioma. El trabajo, que hoy se publica en Nature Comunications, est\u00e1 liderado por la","canonical_url":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/","robots":"max-image-preview:large","keywords":"noticias y actualidad","webmasterTools":{"google-site-verification":"UA-38556648-1","miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/#article","name":"Cient\u00edficos Vall d\u2019Hebron validan uso de un inhibidor en tumores cerebrales | El Digital de Asturias","headline":"Cient\u00edficos Vall d&#8217;Hebron validan uso de un inhibidor en tumores cerebrales","author":{"@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w.jpg","width":800,"height":489},"datePublished":"2014-08-18T18:15:53+02:00","dateModified":"2014-08-18T18:15:53+02:00","inLanguage":"es-ES","mainEntityOfPage":{"@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/#webpage"},"isPartOf":{"@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/#webpage"},"articleSection":"Noticias y Actualidad"},{"@type":"BreadcrumbList","@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/eldigitaldeasturias.com\/magazine365#listItem","position":1,"name":"Home","item":"https:\/\/eldigitaldeasturias.com\/magazine365","nextItem":{"@type":"ListItem","@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/category\/noticias-actualidad\/#listItem","name":"Noticias y Actualidad"}},{"@type":"ListItem","@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/category\/noticias-actualidad\/#listItem","position":2,"name":"Noticias y Actualidad","item":"https:\/\/eldigitaldeasturias.com\/magazine365\/category\/noticias-actualidad\/","nextItem":{"@type":"ListItem","@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/#listItem","name":"Cient\u00edficos Vall d&#8217;Hebron validan uso de un inhibidor en tumores cerebrales"},"previousItem":{"@type":"ListItem","@id":"https:\/\/eldigitaldeasturias.com\/magazine365#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/#listItem","position":3,"name":"Cient\u00edficos Vall d&#8217;Hebron validan uso de un inhibidor en tumores cerebrales","previousItem":{"@type":"ListItem","@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/category\/noticias-actualidad\/#listItem","name":"Noticias y Actualidad"}}]},{"@type":"Organization","@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/#organization","name":"El digital de Asturias","description":"Revista de ocio, turismo y estilo de vida","url":"https:\/\/eldigitaldeasturias.com\/magazine365\/","logo":{"@type":"ImageObject","url":"https:\/\/www.eldigitaldeasturias.com\/noticias\/wp-content\/uploads\/2020\/12\/EDA.jpg","@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/#organizationLogo"},"image":{"@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/author\/admin\/#author","url":"https:\/\/eldigitaldeasturias.com\/magazine365\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/#authorImage","url":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/litespeed\/avatar\/e571bcf59a0edd6fa6838245a470f2fe.jpg?ver=1775154774","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/#webpage","url":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/","name":"Cient\u00edficos Vall d\u2019Hebron validan uso de un inhibidor en tumores cerebrales | El Digital de Asturias","description":"Barcelona, 18 ago (EFE).- Un grupo de cient\u00edficos del hospital Vall d'Hebron de Barcelona ha logrado por primera vez validar el uso de un inhibidor de Myc, una prote\u00edna clave implica en el desarrollo de tumores cerebrales m\u00e1s frecuentes como el glioma. El trabajo, que hoy se publica en Nature Comunications, est\u00e1 liderado por la","inLanguage":"es-ES","isPartOf":{"@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/#website"},"breadcrumb":{"@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/#breadcrumblist"},"author":{"@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/author\/admin\/#author"},"creator":{"@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w.jpg","@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/#mainImage","width":800,"height":489},"primaryImageOfPage":{"@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/#mainImage"},"datePublished":"2014-08-18T18:15:53+02:00","dateModified":"2014-08-18T18:15:53+02:00"},{"@type":"WebSite","@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/#website","url":"https:\/\/eldigitaldeasturias.com\/magazine365\/","name":"El Digital de Asturias","description":"Revista de ocio, turismo y estilo de vida","inLanguage":"es-ES","publisher":{"@id":"https:\/\/eldigitaldeasturias.com\/magazine365\/#organization"}}]},"og:locale":"es_ES","og:site_name":"El Digital de Asturias \u2013 Revista de ocio, turismo y estilo de vida","og:type":"article","og:title":"Cient\u00edficos Vall d\u2019Hebron validan uso de un inhibidor en tumores cerebrales | El Digital de Asturias","og:description":"Barcelona, 18 ago (EFE).- Un grupo de cient\u00edficos del hospital Vall d'Hebron de Barcelona ha logrado por primera vez validar el uso de un inhibidor de Myc, una prote\u00edna clave implica en el desarrollo de tumores cerebrales m\u00e1s frecuentes como el glioma. El trabajo, que hoy se publica en Nature Comunications, est\u00e1 liderado por la","og:url":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/","og:image":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w.jpg","og:image:secure_url":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w.jpg","og:image:width":800,"og:image:height":489,"article:published_time":"2014-08-18T20:15:53+00:00","article:modified_time":"2014-08-18T20:15:53+00:00","twitter:card":"summary_large_image","twitter:title":"Cient\u00edficos Vall d\u2019Hebron validan uso de un inhibidor en tumores cerebrales | El Digital de Asturias","twitter:description":"Barcelona, 18 ago (EFE).- Un grupo de cient\u00edficos del hospital Vall d'Hebron de Barcelona ha logrado por primera vez validar el uso de un inhibidor de Myc, una prote\u00edna clave implica en el desarrollo de tumores cerebrales m\u00e1s frecuentes como el glioma. El trabajo, que hoy se publica en Nature Comunications, est\u00e1 liderado por la","twitter:image":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-content\/uploads\/2014\/08\/6564776w.jpg"},"aioseo_meta_data":{"post_id":"21478","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[],"defaultGraph":"","defaultPostTypeGraph":""},"schema_type":null,"schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"location":null,"local_seo":null,"seo_analyzer_scan_date":"2025-09-17 23:52:02","breadcrumb_settings":null,"limit_modified_date":false,"open_ai":null,"ai":null,"created":"2021-03-09 06:43:39","updated":"2025-09-17 23:52:02"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/eldigitaldeasturias.com\/magazine365\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">\u2013<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/eldigitaldeasturias.com\/magazine365\/category\/noticias-actualidad\/\" title=\"Noticias y Actualidad\">Noticias y Actualidad<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">\u2013<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/\" title=\"Cient\u00edficos Vall d\u2019Hebron validan uso de un inhibidor en tumores cerebrales\">Cient\u00edficos Vall d\u2019Hebron validan uso de un inhibidor en tumores cerebrales<\/a>\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/eldigitaldeasturias.com\/magazine365"},{"label":"Noticias y Actualidad","link":"https:\/\/eldigitaldeasturias.com\/magazine365\/category\/noticias-actualidad\/"},{"label":"Cient\u00edficos Vall d&#8217;Hebron validan uso de un inhibidor en tumores cerebrales","link":"https:\/\/eldigitaldeasturias.com\/magazine365\/cientificos-vall-dhebron-validan-uso-de-un-inhibidor-en-tumores-cerebrales\/"}],"_links":{"self":[{"href":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-json\/wp\/v2\/posts\/21478","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-json\/wp\/v2\/comments?post=21478"}],"version-history":[{"count":0,"href":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-json\/wp\/v2\/posts\/21478\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-json\/wp\/v2\/media\/21479"}],"wp:attachment":[{"href":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-json\/wp\/v2\/media?parent=21478"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-json\/wp\/v2\/categories?post=21478"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eldigitaldeasturias.com\/magazine365\/wp-json\/wp\/v2\/tags?post=21478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}